Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database-Reference-Cited by-同舟云学术

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer: analysis of a Japanese healthcare claims database

Published:2022 Issue:6 Volume:33 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Ueda Akihiko¹^ORCID,Watari Hidemichi²^ORCID,Mandai Masaki¹^ORCID,Fukuhara Shunichi³⁴^ORCID,Sugitani Yasuo⁵^ORCID,Ogino Kiyoko⁶^ORCID,Kamijima Shuichi⁶^ORCID,Enomoto Takayuki⁷^ORCID

Affiliation:

1. Department of Gynecology and Obstetrics, Graduate School of Medicine and Faculty of Medicine, Kyoto University, Kyoto, Japan.

2. Department of Obstetrics and Gynecology, Hokkaido University School of Medicine, Sapporo, Japan.

3. Section of Clinical Epidemiology, Department of Community Medicine, Kyoto University, Kyoto, Japan.

4. Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health (JHSPH), Baltimore, Maryland, USA.

5. Biometrics Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.

6. Medical Science Department, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.

7. Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Publisher

Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy

Subject

Obstetrics and Gynecology,Oncology,General Medicine

Link

https://ejgo.org/pdf/10.3802/jgo.2022.33.e78

Reference21 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. National Cancer Center Japan; Center for Cancer Control and Information Services. Projected cancer statistics [Internet]. Tokyo: National Cancer Center Japan. 2022. cited 2022 Apr 21. Available from: https://ganjoho.jp/reg_stat/statistics/stat/short_pred_en.html

3. Japan Society of Obstetrics and Gynecology. Patient annual report and treatment annual report (in Japanese). Treatment Annual Report for 2013 [Internet]. Tokyo. Japan Society of Obstetrics and Gynecology. 2022. cited 2022 Apr 21. Available from: https://www.jsog.or.jp/modules/committee/index.php?content_id=7#databook

4. Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

5. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Renin–angiotensin–aldosterone system inhibitors are associated with improved paclitaxel-induced peripheral neuropathy in lung cancer: a study using administrative claims data;Supportive Care in Cancer;2023-11-29

2. Association of renin–angiotensin–aldosterone system inhibitors with paclitaxel-induced peripheral neuropathy;2023-07-21

3. Bevacizumab;Reactions Weekly;2023-02-04